A Study to Evaluate the Effects of Aflibercept on QTc Interval in Cancer Patients
Clinicaltrials.gov Identifier:All clinical trials available on ClinicalTrials.gov are given an official number by the United States government. This helps people easily search for and find a certain trial.
Trial details
How far along a trial is in the process. There are several phases: Phase 1, Phase 2, Phase 3 and Phase 4.
Trials that are looking for healthy people to participate.
The disease(s) being studied in a trial.
Cancer
An interventional trial typically studies a potential medicine. An observational trial watches a person's health over time with no investigational medicine given.
Interventional
The new medicine being studied.
aflibercept (AVE0005), placebo
The number of people the researchers want in the trial.
88
Trial summary
The primary objective of this study is to evaluate the effects of aflibercept on the QTc interval in cancer patients.
Secondary objectives are to evaluate the effects of aflibercept on other electrocardiogram (ECG) parameters, clinical safety and pharmakokinetic (PK) parameters.
Trial locations
location(s)